Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | E170D | Missense | 1 |
| BRCA | Breast invasive carcinoma | L94L | Silent | 1 |
| BRCA | Breast invasive carcinoma | M140I | Missense | 1 |
| CESC | Cervical and endocervical cancers | E62A | Missense | 1 |
| COAD | Colon adenocarcinoma | A153V | Missense | 1 |
| COAD | Colon adenocarcinoma | C69R | Missense | 1 |
| ESCA | Esophageal carcinoma | E23* | Nonsense | 1 |
| LIHC | Liver hepatocellular carcinoma | N78D | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | S104* | Nonsense | 1 |
| LIHC | Liver hepatocellular carcinoma | V31V | Silent | 1 |
| LUAD | Lung adenocarcinoma | A75V | Missense | 1 |
| LUAD | Lung adenocarcinoma | D180Y | Missense | 1 |
| LUAD | Lung adenocarcinoma | F48F | Silent | 1 |
| PAAD | Pancreatic adenocarcinoma | I127I | Silent | 1 |
| READ | Rectum adenocarcinoma | W51C | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | A153V | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | G17R | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | A182A | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | A25T | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | G12G | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | G43E | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | K10Q | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | V31V | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | V32M | Missense | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 0 | 6.7 | 0 |
| BRCA | Breast invasive carcinoma | 976 | 14.3 | 6.7 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 0 | 6.7 | 0 |
| COAD | Colon adenocarcinoma | 367 | 0 | 13.3 | 0 |
| ESCA | Esophageal carcinoma | 185 | 0 | 0 | 50 |
| GBM | Glioblastoma multiforme | 283 | 0 | 0 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 0 | 0 | 0 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 0 | 0 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 0 | 0 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 0 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | 0 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 14.3 | 6.7 | 50 |
| LUAD | Lung adenocarcinoma | 533 | 14.3 | 13.3 | 0 |
| LUSC | Lung squamous cell carcinoma | 177 | 0 | 0 | 0 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 0 | 0 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 14.3 | 0 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 0 | 0 | 0 |
| READ | Rectum adenocarcinoma | 122 | 0 | 6.7 | 0 |
| SARC | Sarcoma | 247 | 0 | 0 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 0 | 13.3 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 0 | 0 | 0 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 0 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 42.9 | 26.7 | 0 |